BioArctic AB (publ) (BRCTF)
OTCMKTS · Delayed Price · Currency is USD
34.62
-0.28 (-0.80%)
Dec 15, 2025, 10:34 AM EST
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of $3.06 billion as of December 15, 2025. Its market cap has increased by 96.06% in one year.
Market Cap
3.06B
Enterprise Value
2.86B
Revenue
203.37M
Ranking
n/a
PE Ratio
28.82
Stock Price
$34.62
Market Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 315.33M to 3.06B, an increase of 869.66%. That is a compound annual growth rate of 32.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 3.06B | 91.52% |
| Dec 30, 2024 | 1.60B | -31.92% |
| Dec 29, 2023 | 2.35B | 1.97% |
| Dec 30, 2022 | 2.30B | 98.17% |
| Dec 30, 2021 | 1.16B | 13.19% |
| Dec 30, 2020 | 1.03B | 14.35% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |